Daniel R. Boster

Preclinical safety of recombinant human thrombin.

Erika Giste, R. Ponce, S. Pederson, 2007, Regulatory toxicology and pharmacology : RTP.

Prothrombotic coagulation abnormalities preceding the hemolytic-uremic syndrome.

M. Ciol, Glyn Williams, P. Tarr, 2002, The New England journal of medicine.

Diarrhea etiology in a Children's Hospital Emergency Department: a prospective cohort study.

J. Wells, D. Swerdlow, C. Braden, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Etiology of Diarrhea in Pediatric Outpatient Settings

D. Swerdlow, C. Braden, P. Tarr, 2005, The Pediatric infectious disease journal.

Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis.

Craig S. Wong, P. Tarr, S. Jelacic, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Ciprofloxacin-Resistant Gram-Negative Bacilli in the Fecal Microflora of Children

C. Braden, P. Tarr, James R. Johnson, 2006, Antimicrobial Agents and Chemotherapy.

Platelet-activating factor and Escherichia coli O157:H7 infections

W. Henderson, M. Ciol, Glyn Williams, 2002, Pediatric Nephrology.

Shiga toxin-producing Escherichia coli in children with diarrhea: a prospective point-of-care study.

J. Wells, D. Swerdlow, P. Tarr, 2002, The Journal of pediatrics.

ABO and P1 blood group antigen expression and stx genotype and outcome of childhood Escherichia coli O157:H7 infections.

M. Ciol, A. Stapleton, P. Tarr, 2002, The Journal of infectious diseases.

Analysis of Urinary Escherichia coli Isolates for Ability To Produce Shiga Toxin

A. Stapleton, P. Tarr, James R. Johnson, 2002, Journal of Clinical Microbiology.

ABO and P1 blood group antigen expression and stx genotype and outcome of childhood Escherichia coli O157:H7 infections.

M. Ciol, A. Stapleton, P. Tarr, 2002, The Journal of infectious diseases.